|
This company is doing bloody good work. Literally. Grifols' focus is on producing plasma derivatives (plasma proteins for therapeutic use). This business generates about 70% of the group's annual revenue. Its diagnostic division manufactures devices, instrumentation, and reagents for clinical analysis labs, and markets products and equipment for blood banks. The third line of business, the hospital division, develops pharmaceutical products and medical devices used in hospital pharmacies. Clients include health care professionals and patients in more than 90 countries. Nearly three-quarters of Grifols' total sales come from international markets.
|
| | | Contact Information | |
Address: |
C/ de la Marina, 16-18 planta 26
08005 Barcelona, Spain
| | Phone: | +34-935-710-500 | | Fax: | +34-935-710-267 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 1147.80 M | | Revenue Growth (1 yr): | 10.90% |
|
|
Key People
| | • |
Chairman and CEO:
Victor Grifols Roura
| | • |
VP Operations and CFO:
Javier Contreras Garcia
| | • |
Technical Director:
Vicente Blanquer Torre
|
|
|
